bf/NASDAQ:APLS_icon.jpeg

COM:APELLIS

Apellis Pharmaceuticals, Inc.

  • Stock

USD

Last Close

27.75

22/11 21:00

Market Cap

4.54B

Beta: -

Volume Today

2.66M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-3.96M
-
-10.79M
172.33%
-46.52M
331.16%
-27.12M
41.69%
-51.01M
88.04%
-127.50M
149.97%
-304.71M
138.98%
-344.87M
13.18%
-746.35M
116.41%
-652.17M
12.62%
-528.63M
18.94%
depreciation and amortization
6.26K
-
6.59K
5.25%
11.94K
-
239.68K
-
637K
165.77%
1.49M
134.22%
1.49M
0.34%
1.70M
14.59%
deferred income tax
-271.84K
-
153.69K
-
16.34M
-
103.03M
530.52%
198.26M
92.44%
-368.55M
-
stock based compensation
271.84K
-
659.15K
142.48%
545.70K
17.21%
1.08M
97.73%
5.42M
402.20%
7.73M
42.71%
21.14M
173.42%
45.38M
114.60%
70.67M
55.74%
91.08M
28.89%
105.94M
16.31%
change in working capital
238.81K
-
175.01K
26.71%
628.31K
259.00%
42.57K
93.22%
-1.19M
2,888.00%
-12.04M
914.44%
53.15M
541.43%
19.59M
63.15%
-93.52M
577.49%
-15.70M
83.21%
-200.17M
1,175.12%
accounts receivables
-10.10M
-
2.38M
123.51%
-198.72M
8,466.95%
inventory
-16.32M
-
-69.40M
325.30%
-60.65M
12.61%
accounts payables
219.93K
-
397.66K
80.81%
1.73M
334.01%
69.78K
95.96%
932.30K
1,236.07%
6.59M
606.58%
-1.64M
124.91%
-54K
96.71%
10.49M
19,520.37%
18.69M
78.21%
170K
99.09%
other working capital
18.88K
-
-222.65K
1,279.14%
-1.10M
392.98%
-27.21K
97.52%
-2.12M
7,688.80%
-18.63M
779.00%
54.79M
394.13%
19.64M
64.15%
-77.59M
495.06%
32.63M
142.06%
59.02M
80.86%
other non cash items
271.84K
-
804
99.70%
26.49M
3,294,178.61%
13.56K
-
568.33K
4,090.26%
2.70M
374.67%
15.76M
484.13%
6.33M
59.85%
61.55M
872.86%
394.96M
541.66%
net cash provided by operating activities
-3.44M
-
-9.95M
188.76%
-18.86M
89.57%
-26.00M
37.90%
-46.60M
79.19%
-131.24M
181.66%
-211.14M
60.88%
-160.49M
23.99%
-563.13M
250.88%
-513.75M
8.77%
-594.74M
15.76%
investments in property plant and equipment
-19.95K
-
-1.69M
-
-5.42M
220.20%
-1.10M
79.66%
-1.52M
38.17%
-773K
49.28%
acquisitions net
311.57M
-
-248.72M
179.83%
-61.42M
75.31%
99K
100.16%
purchases of investments
-879.07M
-
-171.28M
80.52%
-331.86M
93.75%
sales maturities of investments
567.50M
-
420M
25.99%
393.28M
6.36%
other investing activites
-311.57M
-
248.72M
179.83%
61.42M
75.31%
net cash used for investing activites
-19.95K
-
-1.69M
-
-316.99M
18,619.95%
247.62M
178.12%
59.89M
75.81%
-674K
101.13%
debt repayment
-274.55K
-
-28.70M
-
-322.87M
1,024.95%
common stock issued
1.72K
-
150.06M
-
131.19M
12.57%
109.58M
16.47%
381.42M
248.07%
380.36M
0.28%
380.12M
0.06%
461.04M
21.29%
common stock repurchased
1.57M
-
2.97M
88.57%
4.24M
42.69%
dividends paid
-322.87M
-
other financing activites
7.44M
-
18.83M
153.24%
41.23M
118.97%
14.86M
63.96%
47.31M
218.32%
709.33K
98.50%
307.66M
43,273.56%
954.93M
210.38%
8.90M
99.07%
-18.70M
310.03%
-66.54M
255.85%
net cash used provided by financing activities
7.16M
-
18.83M
162.95%
41.24M
118.98%
14.86M
63.96%
197.38M
1,227.96%
131.90M
33.17%
388.54M
194.57%
692.18M
78.15%
392.24M
43.33%
365.66M
6.78%
394.50M
7.89%
effect of forex changes on cash
-38.43K
-
4.70K
112.24%
359K
7,535.05%
-2.02M
661.56%
-488K
75.79%
135K
127.66%
net change in cash
3.72M
-
8.86M
138.49%
22.38M
152.47%
-11.14M
149.78%
150.78M
1,453.49%
624.14K
99.59%
175.72M
28,053.66%
215.06M
22.39%
74.71M
65.26%
-88.68M
218.70%
-200.78M
126.40%
cash at beginning of period
1.04M
-
4.76M
356.94%
13.62M
186.30%
36.00M
164.29%
24.86M
30.94%
175.64M
606.43%
176.27M
0.36%
351.99M
99.69%
567.04M
61.10%
641.75M
13.18%
553.07M
13.82%
cash at end of period
4.76M
-
13.62M
186.30%
36.00M
164.29%
24.86M
30.94%
175.64M
606.43%
176.27M
0.36%
351.99M
99.69%
567.04M
61.10%
641.75M
13.18%
553.07M
13.82%
352.30M
36.30%
operating cash flow
-3.44M
-
-9.95M
188.76%
-18.86M
89.57%
-26.00M
37.90%
-46.60M
79.19%
-131.24M
181.66%
-211.14M
60.88%
-160.49M
23.99%
-563.13M
250.88%
-513.75M
8.77%
-594.74M
15.76%
capital expenditure
-19.95K
-
-1.69M
-
-5.42M
220.20%
-1.10M
79.66%
-1.52M
38.17%
-773K
49.28%
free cash flow
-3.44M
-
-9.97M
189.34%
-18.86M
89.19%
-26.00M
37.90%
-46.60M
79.19%
-131.24M
181.66%
-212.83M
62.17%
-165.91M
22.05%
-564.23M
240.08%
-515.27M
8.68%
-595.51M
15.57%

All numbers in USD (except ratios and percentages)